- 专利标题: Medical implants and anti-scarring agents
-
申请号: US11007836申请日: 2004-12-07
-
公开(公告)号: US20050183728A1公开(公告)日: 2005-08-25
- 发明人: William Hunter , David Gravett , Philip Toleikis , Arpita Maiti , Pierre Signore , Richard Liggins
- 申请人: William Hunter , David Gravett , Philip Toleikis , Arpita Maiti , Pierre Signore , Richard Liggins
- 申请人地址: CH Zug 6304
- 专利权人: Angiotech International AG
- 当前专利权人: Angiotech International AG
- 当前专利权人地址: CH Zug 6304
- 主分类号: A61B17/11
- IPC分类号: A61B17/11 ; A61B17/12 ; A61F2/00 ; A61F2/02 ; A61F2/04 ; A61F2/06 ; A61F2/28 ; A61F2/44 ; A61K38/00 ; A61L27/00 ; A61L27/54 ; A61L31/00 ; A61L31/16 ; A61M16/04 ; A61M31/00 ; A61N1/05 ; A62B9/00
摘要:
Implants are used in combination with an anti-scarring agent in order to inhibit scarring that may otherwise occur when the implant is placed within an animal. The agent may be any suitable anti-scarring agent, e.g., a cell cycle inhibitor, and may be used in conjunction with a second pharmaceutical agent, e.g., an antibiotic. Suitable implants include intravascular implants, a vascular graft or wrap implant, an implant for hemodialysis access, an implant that provides an anastomotic connection, ventricular assist implant, a prosthetic heart valve implant, an inferior vena cava filter implant, a peritoneal dialysis catheter implant, a central nervous system shunt, an intraocular lens, an implant for glaucoma drainage, a penile implant, an endotracheal tube, a tracheostomy tube, a gastrointestinal device, and a spinal implant.
信息查询